MedTrace Logo

A Study of Initiation Timing of VTE Prevention After Colorectal Cancer Surgery

NCT06259149 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 914

Last updated 2024-08-09

No results posted yet for this study

Summary

This project intends to conduct a single-center, prospective, observational cohort study to explore the impact of the timing of drug prophylaxis on the risk of postoperative bleeding and the preventive effect of VTE in the prevention and management of postoperative venous thromboembolism (VTE) after colorectal cancer (CRC) surgery in Chinese population, and to determine its application and promotion value. The research results of this project can provide useful reference for optimizing the prevention and management of VTE after CRC operation.

Conditions

Interventions

DRUG

Nardraparin calcium injection

The dose of nardraparin calcium injection is 100AxaIU/kg, adjusted according to the patient's body weight, and is injected subcutaneously once a day

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Zhi-Chun Gu · Department of Pharmacy, Renji Hospital, School of Medicine, Shanghai Jiao Tong University

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2025-05-01
Completion
2025-06-01
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06259149 on ClinicalTrials.gov